MarineMax (HZO) could produce exceptional returns because of its solid growth attributes.
Author archives: Zacks Equity Research
Alcoa (AA) is an Incredible Growth Stock: 3 Reasons Why
Alcoa (AA) possesses solid growth attributes, which could help it handily outperform the market.
Here is Why Growth Investors Should Buy Ashtead Group PLC (ASHTY) Now
Ashtead Group PLC (ASHTY) possesses solid growth attributes, which could help it handily outperform the market.
STMicroelectronics (STM) is an Incredible Growth Stock: 3 Reasons Why
STMicroelectronics (STM) possesses solid growth attributes, which could help it handily outperform the market.
National Storage (NSA) is an Incredible Growth Stock: 3 Reasons Why
National Storage (NSA) could produce exceptional returns because of its solid growth attributes.
Exelixis (EXEL) Q4 Earnings & Revenues Beat, Cabometyx Strong
Exelixis (EXEL) beats on both earnings and revenues in the fourth quarter. Both figures increase on a year-over-year basis.
Will Cincinnati Financial (CINF) Gain on Rising Earnings Estimates?
Cincinnati Financial (CINF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Earnings Estimates Rising for Enterprise Financial Services (EFSC): Will It Gain?
Enterprise Financial Services (EFSC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Why Patrick Industries (PATK) Might be Well Poised for a Surge
Patrick Industries (PATK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Bristol Myers’ (BMY) Breyanzi sBLA Gets FDA’s Priority Review
The FDA accepts Bristol Myers’ (BMY) sBLA for Breyanzi under a priority review as a second-line treatment for relapsed/refractory large B-cell lymphoma. A decision is due on Jun 24, 2022.